| 13 | Patient-specific cancer vaccine
of cultured autologous tumor cells and autologous dendritic
cells RO Dillman, PM Schiltz, R Selvan, C de Leon, C Peterson, K Spencer, A Beatty, C DePriest, LD Beutel Hoag Cancer Center, Newport Beach, CA |
| 14 | Dendritic cells loaded with melanoma
cell lysate induce T cell responses against melanoma shared
antigens in vitro and in melanoma patients Duffour MT1, Nardin A1, Boccaccio Claire1, Bercovici N1, Massicard S1, Pauillac F1, Agrawal S1, Prigent D1, Goxe B1, Latour N1, Heshmati F3, Duriau D2, Lehmann F2, Bruyns C2, Velu T2, Salcedo M1, Abastado JP1 1Immuno Designed Molecules (IDM) Paris, France; 2Erasme Bordet Medical Oncology, ULB Brussels, Belgium; 3Hopital Cochin, Paris, France |
| 15 | Tumor Necrosis Therapy
Antibody/Cytokine Fusion Proteins for the Immunotherapy of Solid
Tumors of the Mouse Peisheng Hu, Jiali Li, Myra Mizokami, Leslie Khawli, and Alan L. Epstein Department of Pathology, USC Keck School of Medicine, Los Angeles, CA |
| 16 | Effects of ABX-EGF, A Fully Human
Anti-EGFr Antibody, in Patients with Advanced Cancer R. Figlin1, A. Belldegrun1, J. Crawford2, M. Lohner3, L. Roskos3, X-D. Yang3, K. Foon3, G. Schwab3, L. Weiner4 1University of California Los Angeles, 2Duke University, 3Abgenix Inc, 4Fox Chase Cancer Center |
| 17 | Modulation of Dendritic Cell Function
by Extracoroporeal Phototherapy in Patients with Chronic Graft-vs-Host
Disease is Associated with Clinical Response Foss, Francine; Gorgun, Gullu; Alcindor, Thierry Hematology Oncology, Tufts New England Medical Center Boston, MA |
| 18 | Comparison of Dendritic Cells
Generated from Patients Primed with GM-CSF or G-CSF versus Unprimed
Patients Garlie, Nina; Aoys, Eric; Lefever, Ann Immunotherapy Program, St. Luke’s Medical Center Milwaukee, WI |
| 19 | Eradication of pancreatic ductal
adenocarcinoma cells and lymphatic/vascular endothelial cells
by induction of D2 apoptotic stage leading to bystander killing
effect after treatment with rhuMAb KDR/Flk-1(VEGFR-2) linked
onto pegylated liposomal VRL (PLVT) Giannios J, Michailakis E Clinical Oncology, General State Hospital of Athens |
| 20 | Interleukin (IL)-12 Augments Monocyte
IL-18 Binding Protein (IL-18BPa) Gene Expression via Interferon
(IFN)-g Gollob JA, Veenstra KG Beth Israel Deaconess Medical Center, Boston, MA |
| 21 | Heavy Chain Ferritin Activates
Immunoregulatory T Cells by Induction of Changes in Antigen
Presenting Cells Christian P. Gray, Peter Hersey Department of Oncology and Immunology, Newcastle Mater Misericordiae Hospital, Newcastle, Australia |
| 22 | T cells specific for cells deficient
in antigen presentation - a novel tool in immunotherapy Grufman P1, van Hall T2, Fredriksson V1, Andersson K1, Laban S2, Offringa R2, Melief CJM2 and Wolpert E1 1MTC, Karolinska Institutet, Stockholm, Sweden; 2Leiden University Medical Center, Leiden, The Netherlands |
| 23 | Induction of mouse renal cell
cancers by streptozotocin in Mice: Adaptation to orthotopic
transplant, metastatic potential, immunogenicity and response
to biological therapy M. Eilene Gruys, Timothy C. Back, Jeff Subleski, Theresa A. Wiltrout, Jong-Keuk Lee, Laura Schmidt, Morihiro Watanabe, Roscoe Stanyon, Lynnette Shorts, Jerrold M. Ward, Jon M. Wigginton, and Robert H. Wiltrout LEI, Experimental Therapeutics Section, NIH, Center for Cancer Research, Frederick, MD |
| 24 | Glioblastoma-secreted IL-8 contributes
to chemotaxis and survival of neutrophils and facilitates tumor
growth in vitro D.O. Halverson¹, M. Martins-Green², R. Salcedo³, J.J. Oppenheim³ and W.J. Murphy¹ ¹IRSP, SAIC Frederick, Frederick, MD; ²Department of Biology, University of California, Riverside, CA; ³Laboratory of Immunoregulation, NCI Frederick, Frederick, MD |
